(TVTX) – Trading Halts
-
Travere Therapeutics (TVTX) Confirms FDA Accelerated Approval of FILSPARITM, the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA Nephropathy
-
Travere Therapeutics (TVTX) Halted, News Pending
-
Back to TVTX Stock Lookup